Also known as Glu-Asp-Arg · EDR tripeptide
Synthetic Glu-Asp-Arg tripeptide studied as a brain/CNS bioregulator.
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) in the Khavinson short-peptide bioregulator series, studied for neuroprotective and CNS-directed effects.
Pinealon (Glu-Asp-Arg) is the brain-directed member of the defined short-peptide bioregulator family. It is studied in the same gene-regulatory framework as Epitalon, but framed around neuronal tissue rather than the pineal/aging axis.
Reported research examined protection of neurons against hypoxic and oxidative stress and effects on cognition in animal models. As with the rest of the class, the data originate largely from one research tradition, independent replication is limited, and it is not FDA-approved.
Proposed gene-regulatory modulation of neuronal gene expression; reported antioxidant / anti-apoptotic effects in neural models.
Behind every vial of Pinealon is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how Pinealon, specifically, is brought into being.
On paper, Pinealon weighs in at roughly 418.4 daltons. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
Assembling Pinealon means roughly 3 coupling cycles on the synthesizer — one protected residue added at a time, which is also 3 chances for an incomplete coupling to seed a deletion impurity. It is a short sequence, which makes the build comparatively tractable — but short does not mean trivial, and purity is still won or lost downstream.
The crude mixture — Pinealon plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of Pinealon proves itself: identity confirmed by mass spectrometry against its ~418.4 Da, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of Pinealon — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
Producing Pinealon to a genuine purity spec means solid-phase synthesis, preparative HPLC purification, and batch quality control — none of it cheap, and none of it something you can verify by eye.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Pinealon is a synthetic Glu-Asp-Arg tripeptide studied as a brain/CNS bioregulator in the Khavinson short-peptide series.
Neuroprotection under oxidative or hypoxic stress and cognition endpoints, mostly in preclinical models.
It is concentrated in a single research tradition and is largely preclinical, so findings are preliminary. This page is a research and educational reference.
Synthetic tetrapeptide investigated for telomerase activity and circadian effects.
ViewThymus-derived polypeptide complex — the founding tissue bioregulator (Cytomax) studied for immune restoration.
ViewSynthetic Lys-Glu dipeptide — the defined short-peptide successor to Thymalin, studied for immune and aging endpoints.
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.